Syncom Healthcare IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 56.25 Cr. The company is based in Mumbai and caters to Healthcare sector. Chartered Capital And Investment is the merchant banker of Syncom Healthcare IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 12th September 2008.
Syncom Healthcare IPO posted revenues of ₹ 62.94 Cr. and PAT of ₹ 4.80 Cr. in FY10 on annualised basis.Financial results of Syncom Healthcare IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Financials | Jul-09 | FY09 | FY08 | FY07 | |
---|---|---|---|---|---|
Balance Sheet
|
|||||
Assets | 62.14 | 58.30 | 50.01 | 38.76 | |
Net Worth | 22.90 | 21.29 | 15.78 | 9.44 | |
Total Debt | 34.80 | 30.99 | 30.38 | 20.18 | |
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
20.98
62.94 |
60.56 | 51.74 | 30.18 | |
EBITDA
EBITDA on annualised basis |
3.33
9.99 |
9.92 | 9.02 | 5.32 | |
PAT
PAT on annualised basis |
1.60
4.80 |
3.81 | 3.66 | 2.74 |
Syncom Healthcare IPO PAT Margin is 7.63 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Syncom Healthcare IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
Particulars | Jul-09 | FY09 | FY08 | FY07 |
---|---|---|---|---|
EBITDA Margin (%) | 15.87 | 16.38 | 17.43 | 17.63 |
PAT Margin (%) | 7.63 | 6.29 | 7.07 | 9.08 |
EPS (₹) | 4.80 | 3.85 | 5.36 | 4.81 |
ROE (%) | 6.99 | 17.90 | 23.19 | 29.03 |
ROCE (%) | [●] | [●] | [●] | [●] |
ROA (%) | 2.57 | 6.54 | 7.32 | 7.07 |
Debt to Equity | 1.52 | 1.46 | 1.93 | 2.14 |
The market Capitalisation of Syncom Healthcare IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Syncom Healthcare IPO prospectus highlights an Return on Equity (ROE) of 6.99 % , Return on Assets (ROA) of 2.57 %, and an EBITDA Margin of 15.87 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Syncom Healthcare IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Syncom Healthcare IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Syncom Healthcare IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Syncom Healthcare IPO reported revenue of ₹ 60.56 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Syncom Healthcare IPO provide insights into sales growth, market demand, and business scalability.
Syncom Healthcare recorded an EBITDA of ₹ 9.99 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Syncom Healthcare Profit After Tax (PAT) is ₹ 4.80 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Syncom Healthcare operates in Healthcare and Healtcare. The Issue is listed on BSE,NSE in Feb, 2010. Syncom Healthcare IPO size was 56.25 with Issue price of 75.00 .
Merchant Banker(s) of Syncom Healthcare IPO: Chartered Capital And Investment Limited
Syncom Healthcare IPO subscription was 5.17 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Syncom Healthcare IPO listed at a listing price of 87.85 against the offer price of 75.00.
The current market price of Syncom Healthcare is .
Why Us?